Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

 

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist
A

Systemic Therapy for BCG Unresponsive NMIBC: 1L IO in Cis-Ineligible mUC, Pembro for High-Risk Disease; Toxicity Concerns & QoL

By Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist FEATURING Arjun Balar
By Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist FEATURING Arjun Balar
0 views
May 5, 2021
Comments 0
Login to view comments. Click here to Login
Videos
09:48
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Managing High-Risk NMIBC: Options When BCG Is Not Effective

Feat. G. Steinberg
08:43
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Novel Therapies for HR-NMIBC: Nadofaragene Firadenov…

Feat. G. Steinberg
08:36
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

High-Risk NMIBC Highlights: Cytokine Therapy, ADCs, Drug Delivery En…

Feat. G. Steinberg
19:53
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond …

Feat. E. Plimack
18:12
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Expert Q&A Session and Case Discussion for Older Patients With M…

Feat. E. Plimack, Y. Lotan, S. Chang, G. Steinberg, L. Barlow, A. Balar, A. Corcoran, A. Sankin
15:19
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Strategies for Organ Preservation in UC: Why Remove Every Bad Bladde…

Feat. A. Sankin
09:28
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Neoadjuvant MIBC: MVAC Followed by RC, Accelerated M…

Feat. A. Balar
07:43
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Adjuvant MIBC: DFS Data for Atezo vs. Observation, D…

Feat. A. Balar
14:06
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Open vs. Robotic Approaches in Radical Cystectomy: Overview of Oncol…

Feat. M. Gupta
19:47
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Strategies for Radical Cystectomy Complications: ERAS Guidelines, Pr…

Feat. A. Corcoran
11:40
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Systemic Therapy for BCG Unresponsive NMIBC: 1L IO in Cis-Ineligible…

Feat. A. Balar
15:21
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

BCG Unresponsiveness and Intravesical Therapy in NMIBC: Cost-Effecti…

Feat. L. Barlow
19:06
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

BCG Shortage - Optimal Patient Selection, Alternatives, and “Upfront…

Feat. R. Matulewicz
18:17
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Quality Indicators and Enhanced Imaging in Cystoscopy and TURBT in N…

Feat. W. Huang
17:48
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Treatment, Surveillance, and Guidelines for NMIBC: H…

Feat. S. Chang
05:54
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Update on Upper Tract Urothelial Cell Carcinoma: Distinguishing Feat…

Feat. Y. Lotan
10:37
Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Upper Tract Urothelial Cell Carcinoma Updates: Endocavitary Treatmen…

Feat. Y. Lotan